The role of speech and language pathologists
Speech and Language Pathologists (SLPs) play a crucial yet often underappreciated role in supporting communication and cognitive development across all age groups. Whether working in hospitals, clinics, schools, or rehabilitation centers, these highly trained professionals are dedicated to helping individuals overcome communication and swallowing challenges that can significantly impact quality of life.
SLPs work with a wide range of people—from children with developmental delays and speech sound disorders to adults recovering from strokes, brain injuries, or managing conditions such as Parkinson's disease and dementia. They also support individuals with hearing loss, fluency disorders like stuttering, and voice impairments. In educational settings, SLPs collaborate with teachers and parents to help children develop language skills essential for academic success and social interaction.
A large part of their work involves personalised assessment and the development of targeted intervention plans. For children, this may involve improving articulation, expanding vocabulary, or fostering language comprehension. For adults, therapy often focuses on restoring lost communication abilities or learning new strategies for effective speech and language use.
SLPs are also critical in addressing swallowing disorders (dysphagia), ensuring that individuals can eat and drink safely—particularly important in healthcare and elderly care settings. Their expertise spans the mechanics of speech production, cognitive-linguistic functions, and even alternative communication methods, such as using devices for those who cannot speak.
As communication is a foundational skill for daily living, learning, and connecting with others, the impact of SLPs is profound. They empower individuals to express themselves, build confidence, and engage more fully with the world around them. In doing so, Speech and Language Pathologists not only restore voices—but also rebuild lives.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
a day ago
- News18
Morten Harket Diagnosed With Parkinson's Disease: ‘I Don't Feel Like Singing'
Last Updated: Morten Harket didn't say exactly when he was diagnosed with Parkinson's, but explained that he takes medicine to control his symptoms. Morten Harket, lead singer of the iconic Norwegian band A-ha, has revealed that he is living with Parkinson's disease. The Take On Me hitmaker shared the news on the band's official website, though he did not specify when he was diagnosed. Harket explained that he is currently managing his symptoms with medication. In addition, he underwent surgery in the United States last year, during which doctors implanted tiny electrodes in his brain. These are connected to a small device in his chest as part of a treatment known as deep brain stimulation (DBS), which has helped stabilise his condition. While the treatment has been largely successful, Harket acknowledged that the disease has impacted his voice. The singer said, 'I've got no problem accepting the diagnosis. With time, I've taken to heart my 94-year-old father's attitude to the way the organism gradually surrenders: 'I use whatever works. ' Part of me wanted to reveal it. It's my need for peace and quiet to work that has been stopping me. I'm trying the best I can to prevent my entire system from going into decline. It's a difficult balancing act between taking the medication and managing its side effects. There's so much to weigh up when you're emulating the masterful way the body handles every complex movement, or social matters and invitations, or day-to-day life in general. You're actually seeing me at my worst right now." Morten Harket's voice, long considered his most distinctive gift, is now beginning to show signs of strain. He admitted that the changes in his voice are one of the main reasons he feels uncertain about his musical future. At times, he experiences sudden drops in energy, moments when everything around him seems to fall silent. Throughout the years, his bandmates Paul and Magne have often written songs that pushed his vocal abilities to the limit, constantly challenging him to deliver his very best. Now, due to the illness, Harket said, 'I don't feel like singing, and for me that's a sign. I'm broad-minded in terms of what I think works; I don't expect to be able to achieve full technical control. I don't know whether I'll be able to manage it at some point in the future. When we tune the frequencies and direction of the electrodes, it is also able to affect the region of the voice, but we're not yet able to capture and control it. If I don't take dopamine, my voice settles down, but then the general underlying symptoms become more pronounced." Morten Harket knows that many people will now send him advice, treatment ideas and suggestions. But he explained that he needs to focus only on the doctors' and experts' advice. He trusts their knowledge and wants to stick to their advice. He also asked people not to worry about him. Instead, he encouraged everyone to focus on their own growth and purpose. He also reminded people to protect nature and care for the environment, as these are the real issues that need attention. The A-ha singer shared that he has been working on new songs for the past few years. He feels that the lyrics show a different, more personal side of him. However, he's not sure if he'll be able to complete and release them. First Published: June 05, 2025, 15:15 IST
Time of India
3 days ago
- Time of India
Four Covid-linked deaths take toll in Maharashtra to 14
MUMBAI: Four fatalities were added Tuesday to the list of Covid-19 patients who have died in the state since cases began emerging in May, taking the toll to 14. In Maharashtra, two deaths occurred in Nagpur, one in Chandrapur, and one in Miraj. Tired of too many ads? go ad free now Elsewhere, a death each was recorded in Kerala, Tamil Nadu and West Bengal. All the new deaths in the state - it was not immediately known over what period they occurred - and outside it, involved patients with co-morbidities. Of the 86 new Covid cases in state on Tuesday, 26 were from Mumbai, 9 from Thane, 6 from Navi Mumbai, and one each from Kalyan and Ulhasnagar. The total number of cases in the country has touched 4,026. One of the four state death was of a patient who had cardiac arrhythmia and COPD with chronic bronchitis. The national toll - which took into account 10 deaths in state - rose to 37. In the state, one of the four latest deaths was of a patient who had cardiac arrhythmia and COPD with chronic bronchitis. Another had Parkinson's disease and hypertension, while one had diabetes, hypertension, and chronic renal failure. The fourth patient was immunocompromised and suffered from ischemic heart disease (IHD) and tuberculosis. Four new cases were reported from from Nashik city, three from Pune district, 24 from Pune city, three from Pimpri-Chinchwad, two from Kolhapur, one from Sangli district, four from Sangli, and two from Nagpur. Mumbai's total number of Covid-19 cases since May now stands at 509. There had also been three deaths in the city, all involving patients with severe comorbidities. Doctors told TOI that most patients, even those with comorbidities, are recovering. The state health department on Monday asked civic bodies to conduct mock drills of all the pressure swing absorption oxygen plants.
Time of India
3 days ago
- Time of India
Harvard seeks end to US funding cuts, says national security, public health research in peril
Wilmington, Delaware -Harvard University asked a federal judge on Monday to issue a summary judgment ruling to unfreeze $2.5 billion in funding blocked by President Donald Trump's administration, which Harvard said was illegal. Harvard's filing in the U.S. District Court in Boston said that it had received 957 orders since April 14 to freeze funding for research pertaining to national security threats, cancer and infectious diseases and more since the country's oldest and wealthiest school rejected a White House list of demands. Trump has said he is trying to force change at Harvard - and other top-level universities across the U.S. - because in his view they have been captured by leftist "woke" thought and become bastions of antisemitism. The Trump administration did not immediately respond to a request for comment. U.S. District Judge Allison Burroughs has set arguments for July 21 on Harvard's motion for summary judgment, which is a request for a judge to decide a dispute without a trial to determine material facts. Harvard sued the Trump administration in April, alleging the funding freeze violated the school's right to free speech and was arbitrary and capricious. In Monday's court filing, Harvard detailed the terminated grants, including $88 million for research into pediatric HIV, $12 million for increasing Defense Department awareness of emerging biological threats and $8 million to better understand dark energy. The school said ending the funding would destroy ongoing research into cancer treatments, infectious disease and Parkinson's. The Trump administration has opened numerous investigations into Harvard. Some are looking at threats against Jewish students and faculty after pro-Palestinian protests broke out following the Oct. 7, 2023 Hamas attack on Israel and subsequent Israeli military actions in Gaza. Other investigations are probing whether Harvard discriminates based on sex and gender, along with the school's ties to foreign governments and international students. The Trump administration revoked Harvard's ability to enroll international students last month, which a judge temporarily blocked after Harvard sued in a separate case. Harvard and other universities say Trump's attacks are threats to freedom of speech and freedom of academics, as well as threats to the schools' very existence.
